NCT00213694已完成不适用
Efficacy of Docetaxel (J 15) and Celecoxib in Metastatic Prostate Cancer
University Hospital, Rouen1 个研究点 分布在 1 个国家目标入组 52 人开始时间: 2003年11月最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 52
- 试验地点
- 1
研究概览
简要总结
Clinical response to chemotherapy. Biological parameter (PSA) and RECIST evaluation. Association of Docetaxel (J 15) and Celecoxib.
详细描述
Association Docetaxel (J 15) and celecoxib Patient survival Biological parameter : PSA Clinical status RECIST evaluation
研究设计
- 研究类型
- Observational
- 时间视角
- Prospective
入排标准
- 性别
- Male
- 接受健康志愿者
- 否
入选标准
- •metastatic prostate cancer
- •ASCO progression criteria
排除标准
- •other prostate chemotherapy
研究者
研究点 (1)
Loading locations...
相似试验
撤回
1 期
Docetaxel, Doxorubicin, and Cyclophosphamide in Treating Women With Advanced Breast CancerBreast CancerNCT00074139Case Comprehensive Cancer Center
终止
2 期
Docetaxel and Cisplatin in Treating Patients With Stage III or Stage IV Non-Small Cell Lung CancerLung CancerNCT00118131University of Medicine and Dentistry of New Jersey49
已完成
1 期
Docetaxel, Capecitabine, and Cisplatin in Treating Patients With Advanced Solid TumorsUnspecified Adult Solid Tumor, Protocol SpecificNCT00084734Roswell Park Cancer Institute61
已完成
2 期
Docetaxel, Gemcitabine, and Filgrastim (G-CSF) or Pegfilgrastim in Treating Patients With Advanced, Persistent, or Recurrent Uterine LeiomyosarcomaSarcomaNCT00101127Gynecologic Oncology Group
已完成
2 期
Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube CancerFallopian Tube CancerPrimary Peritoneal Cavity CancerOvarian CancerNCT00569673Gynecologic Oncology Group71